scholarly article | Q13442814 |
P50 | author | Sharon Saydah | Q90123741 |
Catherine M Loria | Q117242597 | ||
P2093 | author name string | Frederick L Brancati | |
Mark S Eberhardt | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glycobiology | Q899224 |
glucose | Q37525 | ||
P304 | page(s) | 1092-1100 | |
P577 | publication date | 2003-06-01 | |
P1433 | published in | American Journal of Epidemiology | Q4744243 |
P1476 | title | Abnormal glucose tolerance and the risk of cancer death in the United States | |
P478 | volume | 157 |
Q37400511 | A cohort study of the risk of cancer associated with type 2 diabetes |
Q34538052 | A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer |
Q27331637 | Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment |
Q39648521 | All-cause cancer mortality over 15 years in multi-ethnic Mauritius: the impact of diabetes and intermediate forms of glucose tolerance |
Q51349843 | Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. |
Q57152332 | Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study |
Q37356443 | Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin |
Q37155599 | Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma |
Q34222524 | Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region |
Q21090132 | Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts |
Q54570063 | Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. |
Q35104958 | Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations |
Q51370357 | Categories of glucose tolerance and continuous glycemic measures and mortality. |
Q38684987 | Chemotherapy and Glycemic Control in Patients with Type 2 Diabetes and Cancer: A Comparative Case Analysis |
Q37684154 | Consensus on the Prevention of Type 2 Diabetes in Chinese Adults |
Q46171495 | Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. |
Q27657527 | Design of an Insulin Analog with Enhanced Receptor Binding Selectivity: RATIONALE, STRUCTURE, AND THERAPEUTIC IMPLICATIONS |
Q47665989 | Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System |
Q38097984 | Diabetes and cancer relationships |
Q36047297 | Diabetes and lung cancer among postmenopausal women |
Q36637909 | Diabetes and risk of cancer |
Q44370016 | Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy |
Q43057683 | Diabetes, prediabetes and cancer mortality |
Q41842666 | Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus? |
Q36677131 | Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program). |
Q34520129 | Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare. |
Q51501226 | Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. |
Q51343811 | Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study. |
Q54649308 | Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus. |
Q44737786 | Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel |
Q37364601 | Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study |
Q44962985 | Glycemic index and colorectal carcinogenesis |
Q43541452 | Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease |
Q37375845 | HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women |
Q37199364 | High prevalence of diabetes mellitus and impaired glucose tolerance in liver cancer patients: A hospital based study of 4610 patients with benign tumors or specific cancers |
Q34076153 | Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock |
Q30912182 | Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data |
Q59265277 | Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer |
Q34925766 | Increased risk of colon cancer in men in the pre-diabetes phase |
Q35554181 | Inhibitory effect of metformin therapy on the incidence of colorectal advanced adenomas in patients with diabetes |
Q55385002 | Insulin glargine affects the expression of Igf-1r, Insr, and Igf-1 genes in colon and liver of diabetic rats. |
Q35578858 | Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers |
Q34989798 | Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients |
Q34976375 | Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis |
Q37554697 | Metformin effects revisited |
Q34424886 | Metformin for aging and cancer prevention |
Q35828675 | Metformin potentiates rapamycin and cisplatin in gastric cancer in mice |
Q36524748 | Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning |
Q61805534 | Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: The Asturias Study |
Q35137438 | On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test. |
Q37630970 | Plasma glucose regulation and mortality in Korea: a pooled analysis of three community-based cohort studies |
Q36769486 | Pre-diagnosis blood glucose and prognosis in women with breast cancer. |
Q33879153 | Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai |
Q35246551 | Prediabetes and the risk of cancer: a meta-analysis. |
Q37094633 | Proteinuria as a risk factor for mortality in patients with colorectal cancer |
Q53628117 | Relationship between HbA(1)c and mortality in a Japanese population. |
Q37483954 | Relationship between level of HbA1C and breast cancer |
Q36461174 | Relationship between metabolic syndrome and thyroid nodules in healthy Koreans |
Q40131499 | Response to Intravenous Glucose-Tolerance Test and Risk of Cancer: A Long-Term Prospective Cohort Study |
Q34234264 | Risk of cancer in a large cohort of U.S. veterans with diabetes. |
Q35059999 | Serum glucose and risk of cancer: a meta-analysis |
Q33585663 | Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians |
Q34153922 | Survival of Women with Colon Cancer in Relation to Precancer Anthropometric Characteristics: the Iowa Women's Health Study |
Q33893799 | The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer |
Q26991486 | The metabolic and mitogenic properties of basal insulin analogues |
Q36303910 | Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer |
Q33795313 | Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals |
Q37651046 | Undiagnosed diabetes in breast, colorectal, lung, and prostate cancer: incidence and risk factors. |
Search more.